These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7971455)

  • 21. Transfusion-associated graft-versus-host disease with transfusion practice in cardiac surgery.
    Yasuura K; Okamoto H; Matsuura A
    J Cardiovasc Surg (Torino); 2000 Jun; 41(3):377-80. PubMed ID: 10952326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor.
    Ryo R; Saigo K; Hashimoto M; Kohsaki M; Yasufuku M; Watanabe N; Okada M; Tadokoro K; Juji T
    Vox Sang; 1999; 76(4):241-6. PubMed ID: 10394145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease.
    McMilin KD; Johnson RL
    Transfus Med Rev; 1993 Jan; 7(1):37-41. PubMed ID: 8431657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.
    Kurtzberg J; Laughlin M; Graham ML; Smith C; Olson JF; Halperin EC; Ciocci G; Carrier C; Stevens CE; Rubinstein P
    N Engl J Med; 1996 Jul; 335(3):157-66. PubMed ID: 8657213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graft-versus-host disease: introduction and prospect.
    Ohto H; Suzuki H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of graft-versus-host disease following irradiated fresh blood transfusion].
    Mishima A; Takeuchi Y; Ueda N; Sato M; Terada J; Kamiya Y; Okubo T; Usami S; Kotani H; Suzuki Y
    Kyobu Geka; 1991 Sep; 44(10):825-7. PubMed ID: 1920999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes.
    Wagner FF; Flegel WA
    Transfusion; 1995 Apr; 35(4):284-91. PubMed ID: 7701545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An immunohistological study of post-transfusion graft-versus-host disease (GVHD).
    Hojo H; Kainuma Y; Kunori T; Wachi E; Wakasa H
    Fukushima J Med Sci; 1993 Dec; 39(2):77-87. PubMed ID: 7927138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion associated graft versus host disease in an immunocompetent patient.
    O'Connor NT; Mackintosh P
    J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfusion associated graft versus host disease.
    Tipu HN; Ahmed TA; Khalilullah ; Ahmed S; Satti T; Ahmed P
    J Pak Med Assoc; 2008 Mar; 58(3):143-5. PubMed ID: 18517122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative erythroderma with change of HLA phenotypes from heterozygotes to homozygotes: a report of two cases.
    Ito K; Fujita M; Norioka M; Yoshida H; Arii S; Tanaka J; Tobe T; Kakuyama M; Maruya E; Saji H
    Eur J Haematol; 1991 Apr; 46(4):217-22. PubMed ID: 1826657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
    Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
    Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restricted use of T-cell receptor V beta genes in posttransfusion graft-versus-host disease.
    Wang L; Tadokoro K; Tokunaga K; Uchida S; Moriyama S; Bannai M; Mitsunaga S; Takai K; Juji T
    Transfusion; 1997; 37(11-12):1184-91. PubMed ID: 9426644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?
    Kanter MH
    Transfusion; 1992 May; 32(4):323-7. PubMed ID: 1585436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential for transfusion-associated graft-versus-host disease due to apheresis platelets matched for HLA class I antigens.
    Grishaber JE; Birney SM; Strauss RG
    Transfusion; 1993; 33(11):910-4. PubMed ID: 8259596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.
    Thaler M; Shamiss A; Orgad S; Huszar M; Nussinovitch N; Meisel S; Gazit E; Lavee J; Smolinsky A
    N Engl J Med; 1989 Jul; 321(1):25-8. PubMed ID: 2786605
    [No Abstract]   [Full Text] [Related]  

  • 37. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transfusion-associated graft-vs-host disease in a patient with Hodgkin's disease].
    Lillevang ST; Andersen CB; Schmidt KG; Riisom K
    Ugeskr Laeger; 1992 Oct; 154(43):2979-80. PubMed ID: 1462387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion of peripheral blood stem cells from donor homozygous for a shared HLA-haplotype: avoiding fatal transfusion-associated graft-versus-host disease while preserving anti-leukemic effect.
    Wong R; Lau FY; Chui CH; Tsang KS; Chik KW; Li CK; Cheng G
    Transplantation; 2001 Feb; 71(3):487-90. PubMed ID: 11233917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.
    Delbos F; Barhoumi W; Cabanne L; Beckerich F; Robin C; Redjoul R; Astati S; Toma A; Pautas C; Ansart-Pirenne H; Cordonnier C; Bierling P; Maury S
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):292-299. PubMed ID: 26453972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.